Protagenic Therapeutic is a biopharmaceutical company focusing on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Co.'s proprietary compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide (TCAP), an endogenous brain signaling peptide that can dampen overactive stress responses. Additionally, Co. is engaged in the research and development of follow-on compounds in the TCAP family. The PTIX stock yearly return is shown above.
The yearly return on the PTIX stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2021 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the PTIX annual return calculation with any dividends reinvested as applicable (on ex-dates).
|